Nemus Bioscience Announces $20 Million Series E COSTA MESA, CA–(Marketwired – May 4, 2017) – NEMUS Bioscience, Inc. (OTCQB: NMUS) (the “Company”) today announced the signing of a private...

Milestone Study Shows Dramatic Reduction In Pharmaceutical Reliance Among Canadian Medical Cannabis Patients Canabo Medical Inc. observational study finds nearly fifty per cent drop in benzodiazepine use within months...